These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39639064)
1. Toll-like receptor 3 signaling attenuated colitis-associated cancer development in mice. Chung KY; Kim S; Yoon HT; Kwon SH; Park HS; Im JP; Kim JS; Kim JW; Han YM; Koh SJ Sci Rep; 2024 Dec; 14(1):30308. PubMed ID: 39639064 [TBL] [Abstract][Full Text] [Related]
2. Altered gut metabolites and metabolic reprogramming involved in the pathogenesis of colitis-associated colorectal cancer and the transition of colon "inflammation to cancer". Wang D; Zhu L; Liu H; Feng X; Zhang C; Liu B; Li T; Liu L; Chang H; Sun J; Yang L; Yang W J Pharm Biomed Anal; 2025 Jan; 253():116553. PubMed ID: 39486392 [TBL] [Abstract][Full Text] [Related]
3. Neohesperidin protects against colitis-associated colorectal cancer in mice via suppression of the NF-κB/p65 and MAPK pathways. Cao X; Li L; Hu J; Zhu S; Song S; Kong S; Zhou L; Huang Y J Nutr Biochem; 2025 Feb; 136():109804. PubMed ID: 39547268 [TBL] [Abstract][Full Text] [Related]
4. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
5. Daikenchuto, a Japanese herbal medicine, ameliorates experimental colitis in a murine model by inducing secretory leukocyte protease inhibitor and modulating the gut microbiota. Ozaka S; Sonoda A; Kudo Y; Ito K; Kamiyama N; Sachi N; Chalalai T; Kagoshima Y; Soga Y; Ekronarongchai S; Ariki S; Mizukami K; Ishizawa S; Nishiyama M; Murakami K; Takeda K; Kobayashi T Front Immunol; 2024; 15():1457562. PubMed ID: 39524440 [TBL] [Abstract][Full Text] [Related]
7. Interventions for preventing weight gain after smoking cessation. Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006219. PubMed ID: 34611902 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]